Endocardial carbon-braid electrodes. A new concept for lower defibrillation thresholds.

BACKGROUND In the treatment of patients with life-threatening ventricular arrhythmia, transvenous implantable cardioverter/defibrillators provide significant advantages over devices requiring a thoracotomy. This study tested the hypothesis that a new carbon-fiber electrode, designed at the Technische Universität in Munich, Germany, has a lower defibrillation threshold (DFT) than standard transvenous defibrillation electrodes. METHODS AND RESULTS In 8 mongrel dogs (weight, 25.2 +/- 0.8 kg; heart weight, 192 +/- 19 g), we examined the efficacy and electrical characteristics of a right ventricular endocardial carbon prototype defibrillation electrode (9.5F, 4.4-cm2 surface) compared with a standard CPI 0062 Endotak electrode and a Medtronic 6966 Transvene endocardial right ventricular defibrillation electrode. The new electrode consists of 24 braided, tubular carbon filaments, each containing 1000 highly isotropic carbon fibers of 7-microns diameter, yielding a theoretical electrical surface of 480 cm2. The DFTs were determined in random order between each of the three right ventricular electrodes and a subcutaneous wire array anode placed on the left thorax. A standard step-down/up DFT protocol of 20-V shock steps was applied. Two different biphasic waveforms with a 1-ms delay between phases were tested: 3.2-ms first phase/2.0-ms second phase, and 6.0-ms first phase/6.0-ms second phase. For the 3.2/2.0-ms waveform, we found a significantly lower DFT for the carbon lead (4.96 +/- 1.58 J) compared with the CPI 0062 (6.93 +/- 1.67 J) and the Medtronic 6966 (7.49 +/- 0.99 J) leads. For the 6.0/6.0-ms waveform, the DFT for the carbon electrode (5.97 +/- 2.09 J) was significantly lower than for the Medtronic 6966 lead (8.55 +/- 1.93 J) but not for the CPI 0062 lead (6.30 +/- 1.41 J). The impedance with carbon was lower than with the other two leads for the 6.0/6.0-ms waveform but not for the 3.2/2.0-ms waveform. For the carbon electrode, the 3.2/2.0-ms waveform had a lower DFT than the 6.0/6.0-ms waveform. CONCLUSIONS The present canine study found a lower DFT for a new carbon electrode compared with DFTs for endocardial defibrillation electrodes made of standard metal. Further long-term animal studies and clinical studies are needed to determine whether carbon materials and braided-lead technology are practical and beneficial in patients.

[1]  L. Epstein,et al.  Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. , 1994, Circulation.

[2]  W. M. Smith,et al.  Improved defibrillation threshold with a new epicardial carbon electrode compared with a standard epicardial titanium patch. , 1995, Circulation.

[3]  W. Jung,et al.  Failure of an Implantable Cardioverter‐ Defibrillator to Redetect Ventricular Fibrillation in Patients With a Nonthoracotomy Lead System , 1992, Circulation.

[4]  P. Wolf,et al.  Why Do Some Patients Have High Defibrillation Thresholds at Defibrillator Implantation? , 1994, Pacing and clinical electrophysiology : PACE.

[5]  G. Kay,et al.  Clinical Characteristics and Outcome of Patients With High Defibrillation Thresholds: A Multicenter Study , 1992, Circulation.

[6]  G. Guiraudon,et al.  A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation. , 1992, Circulation.

[7]  R. Fogoros,et al.  Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. , 1990, Journal of the American College of Cardiology.

[8]  C. Babbs.  Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs. , 1978, American heart journal.

[9]  S. Saksena,et al.  Simultaneous Biphasic Shocks Enhance Efficacy of Endocardial Cardioversion Defibrillation in Man , 1991, Pacing and clinical electrophysiology : PACE.

[10]  J. Ruskin,et al.  Mortality benefits and the implantable cardioverter-defibrillator. , 1994, Circulation.

[11]  J. Fisher,et al.  Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. , 1991, Journal of the American College of Cardiology.

[12]  S. Saksena,et al.  Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. , 1993, The American journal of cardiology.

[13]  S. Saksena,et al.  Low‐Energy Endocardial Defibrillation Using an Axillary or a Pectoral Thoracic Electrode Location , 1993, Circulation.

[14]  S. Higgins,et al.  The Subcutaneous Array: A New Lead Adjunct for the Transvenous ICD to Lower Defibrillation Thresholds , 1995, Pacing and clinical electrophysiology : PACE.

[15]  E. Fain,et al.  Comparison of defibrillation efficacy in humans using a new catheter and superior vena cava spring-left ventricular patch electrodes. , 1988, Journal of the American College of Cardiology.

[16]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.

[17]  P. Wolf,et al.  Defibrillation with Low Voltage using a Left Ventricular Catheter and Four Cutaneous Patch Electrodes in Dogs , 1991, Pacing and clinical electrophysiology : PACE.

[18]  E. Alt,et al.  A New Approach Towards Defibrillation Electrodes: Highly Conductive Isotropic Carbon Fibers , 1991, Pacing and clinical electrophysiology : PACE.

[19]  George A. Johnson,et al.  A Simplified, Single‐Lead Unipolar Transvenous Cardioversion‐Defibrillation System , 1993, Circulation.

[20]  P D Wolf,et al.  Cardiac Potential and Potential Gradient Fields Generated by Single, Combined, and Sequential Shocks During Ventricular Defibrillation , 1992, Circulation.

[21]  B. Levander,et al.  Strength of implanted carbon fibers. Studies of the lumbar spine in goats. , 1988, Acta orthopaedica Scandinavica.

[22]  P. Wolf,et al.  Strength-duration and probability of success curves for defibrillation with biphasic waveforms. , 1990, Circulation.

[23]  Jacques Mugica,et al.  New perspectives in cardiac pacing , 1988 .

[24]  F. Marchlinski.  Nonthoracotomy defibrillator lead systems. A welcomed addition but still a lot to learn. , 1993, Circulation.

[25]  L A Geddes,et al.  Strength-duration curves for trapezoidal waveforms of various tilts for transchest defibrillation in animals. , 1978, Medical instrumentation.

[26]  B. Wilkoff,et al.  Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. , 1991, Journal of the American College of Cardiology.

[27]  McDaniel Wc,et al.  The cardiac ventricular defibrillation threshold: inherent limitations in its application and interpretation. , 1987 .

[28]  R E Ideker,et al.  Optical measurements of transmembrane potential changes during electric field stimulation of ventricular cells. , 1993, Circulation research.

[29]  S. D. Bruck,et al.  Properties of Biomaterials in the Physiological Environment , 1980 .

[30]  R. Winkle,et al.  Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. , 1990, Circulation.

[31]  George A. Johnson,et al.  Implantable transvenous cardioverter-defibrillators. , 1993, Circulation.

[32]  R. Winkle,et al.  Mortality in patients with implanted automatic defibrillators. , 1983, Annals of internal medicine.

[33]  R. Sweeney,et al.  The Defibrillation Threshold: A Comparison of Anesthetics and Measurement Methods , 1993, Pacing and clinical electrophysiology : PACE.

[34]  P. Tchou,et al.  Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. , 1988, Annals of internal medicine.

[35]  L. Henry,et al.  Clinical Experience with 910 Carbon Tip Leads: Comparison with Polished Platinum Leads , 1986, Pacing and clinical electrophysiology : PACE.

[36]  E. Fain,et al.  The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept. , 1987, American heart journal.

[37]  S. Pinski,et al.  Patients with a high defibrillation threshold: clinical characteristics, management, and outcome. , 1991, American heart journal.

[38]  R E Ideker,et al.  Ventricular defibrillation using biphasic waveforms: the importance of phasic duration. , 1989, Journal of the American College of Cardiology.

[39]  M. Allen,et al.  A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans. , 1989, Journal of the American College of Cardiology.

[40]  J. Mugica,et al.  Electrode‐Heart Interface: Definition of the Ideal Electrode , 1983, Pacing and clinical electrophysiology : PACE.

[41]  George A. Johnson,et al.  Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. , 1994, Circulation.

[42]  P D Wolf,et al.  Three‐dimensional Potential Gradient Fields Generated by Intracardiac Catheter and Cutaneous Patch Electrodes , 1992, Circulation.

[43]  Studies of the Tissue Reaction Induced by Transvenous Pacemaker Electrodes. I. Microscopic Examination of the Extent of Connective Tissue Around the Electrode Tip in the Human Right Ventricle , 1988, Pacing and clinical electrophysiology : PACE.

[44]  G A Ewy,et al.  Myocardial Necrosis from Direct Current Countershock: Effect of Paddle Electrode Size and Time Interval Between Discharges , 1974, Circulation.

[45]  R. Fogoros,et al.  The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. , 1987, Annals of internal medicine.

[46]  R. Ideker,et al.  Basic mechanisms of defibrillation. , 1990, Journal of electrocardiology.

[47]  S. Saksena.  Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions. , 1993, Pacing and clinical electrophysiology : PACE.